Related by context. All words. (Click for frequent words.) 71 ADAS cog 69 ADAS Cog 69 State Examination MMSE 68 MMSE score 68 UPDRS 68 Alzheimer Disease Assessment 65 Mini Mental 65 subscale scores 64 Montgomery Åsberg Depression 63 Unified Parkinson Disease 63 Brief Psychiatric 63 subscore 62 HADS 62 NIH CPSI 62 subscores 62 interrater reliability 62 MADRS score 62 State Exam MMSE 62 subscales 62 Montgomery Asberg Depression 62 Rating Scale MADRS 62 symptom severity 61 Score DAS# 61 Visual Analogue Scale VAS 61 IPSS 61 WOMAC pain 61 ADCS ADL 61 Crohn Disease Activity 61 DAS# [002] 61 subtest 61 Scale Cognitive Subscale 61 Symptom Checklist 61 Glasgow Coma Scale 60 MMSE scores 60 WAIS III 60 HDRS 60 Y BOCS 60 PANSS 60 NIHSS 60 Rating Scale UPDRS 60 Index CDAI 60 Status Scale EDSS 60 ANOVA 60 Rating Scale BPRS 60 subtests 60 IBDQ 60 ADHD RS 60 QoL 60 PANSS total 60 HAQ DI 60 WOMAC 60 ADCS CGIC 59 Pearson correlation coefficient 59 Visual Analog Scale 59 Expanded Disability Status 59 EDSS 59 unpaired t 59 HAM D 59 APACHE II 59 apnea hypopnea index 59 HbA 1c 59 Neuropsychiatric Inventory 59 BPRS 59 HAM D# 59 Hamilton Rating Scale 59 intraclass correlation coefficients 59 OGTT 59 chi squared 59 EQ 5D 59 Wechsler Adult 59 YMRS 59 EDSS score 59 retest reliability 58 Brief Pain 58 HOMA IR 58 HbA 1c levels 58 Score IPSS 58 postintervention 58 NYHA functional class 58 Global Impression CGI 58 BMI z 58 Epworth Sleepiness Scale 58 Scale cognitive subscale 58 HRQoL 58 PSQI 58 Pain Rating Scale 58 CDAI 58 LVEF 58 CDAI score 58 mTSS 58 neurocognitive function 58 Health Assessment Questionnaire 58 Fibromyalgia Impact Questionnaire 58 sd = 58 glycated hemoglobin 58 autonomic dysfunction 58 International Prostate Symptom 58 correlation coefficients 58 PHQ 9 57 VFQ 57 multivariable analysis 57 posttreatment 57 univariate analyzes 57 amnestic MCI 57 univariate 57 premorbid 57 Disease Activity 57 macroalbuminuria 57 univariate analysis 57 Cronbach alpha 57 HRQL 57 multivariate Cox 57 multivariate analyzes 57 HAMD 57 Kruskal Wallis test 57 thyroglobulin 57 clinically meaningful improvement 57 Oswestry Disability Index 57 covariate 57 Neuropsychiatric Inventory NPI 56 UPDRS motor 56 DAS# scores 56 MADRS 56 mRS 56 point Likert scale 56 depressive symptom 56 PSADT 56 liver histology 56 Rating Scale 56 fasting insulin 56 logistic regression analyzes 56 P = .# 56 SF #v# 56 CORE OM 56 SGRQ 56 Pain Intensity 56 IIEF 56 logistic regression model 56 NIHSS score 56 mL/min/#.# m 2 56 Scale EDSS score 56 definite stent thrombosis 56 posttest 56 interobserver 56 Wilcoxon rank sum 56 nonsignificant 56 Ocular Surface Disease 56 affective psychosis 56 ADHD Rating Scale 56 Scale EDSS 56 HRQOL 56 biopsy Gleason 56 glomerular filtration rate 56 albumin excretion rate 56 symptomatic VTE 56 Primary endpoints 56 MetS 56 Visual Analog 56 endometrial thickness 55 PSA nadir 55 Likert scale 55 pT2 55 Hb A1C 55 biochemical recurrence 55 HbA 1C 55 Interrater reliability 55 ANCOVA 55 confidence intervals CIs 55 EDSS scores 55 microalbuminuria 55 Depression Inventory 55 depressive symptomatology 55 virological response 55 Inventory BPI 55 Kaplan Meier analysis 55 Negative Syndrome 55 allele frequencies 55 p = .# [002] 55 Main Outcome Measures 55 Descriptive statistics 55 euthymic patients 55 fasting plasma glucose 55 SCr 55 CI -#.# 55 Stroke Scale 55 variance ANOVA 55 mg BID dose 55 clinically meaningful improvements 55 carotid IMT 55 QIDS SR 55 CIBIC plus 55 FDG PET imaging 55 virologic response 55 QRS duration 55 % Confidence Interval 55 nonfatal MI 55 Subgroup analyzes 55 intraclass correlation coefficient 54 TNSS 54 alanine aminotransferase ALT 54 bivariate analysis 54 lowest tertile 54 Univariate 54 preoperative PSA 54 cognitive domains 54 â ‰ ¥ 54 logistic regression analysis 54 covariance ANCOVA 54 fasting blood glucose 54 albumin excretion 54 adenoma recurrence 54 psychometric properties 54 baseline HbA1c 54 intraobserver 54 Geriatric Depression 54 ETDRS 54 F FDG PET 54 hsCRP 54 coronary stenosis 54 Subgroup analysis 54 convergent validity 54 lumbar spine BMD 54 colorectal adenoma 54 T2DM 54 FACIT Fatigue 54 exploratory endpoints 54 timepoints 54 Bonferroni correction 54 EORTC QLQ C# 54 IRLS score 54 bivariate 54 p = #.# [003] 54 tertile 54 Psoriasis Area 54 cognitive affective 54 urinary N telopeptide 54 pairwise comparisons 54 rs# [004] 54 QTc 54 alanine aminotransferase 54 WOMAC scores 54 periprocedural 54 DSM IV diagnosis 54 multiple linear regression 54 NIS LL 54 Depressive symptoms 54 Index CDAI score 54 Seattle Angina Questionnaire 54 poststroke 54 intima media thickness 54 CFQ R 54 aspartate aminotransferase AST 54 hemoglobin A1c levels 54 white matter hyperintensities 54 hippocampal atrophy 54 Postoperative 54 elevated ALT 54 highest tertile 54 chi ^ sup 53 interobserver reliability 53 glycosylated hemoglobin 53 cognitive function 53 semiquantitative 53 IELT 53 regression coefficient 53 CHADS 53 HbA1c levels 53 D dimer 53 femoral neck BMD 53 CHADS2 53 specific antigen PSA 53 Likert 53 DLTs 53 syndromal 53 KOOS 53 biochemical relapse 53 SELENA SLEDAI 53 FACIT 53 Incontinence Impact Questionnaire 53 Clinician Administered PTSD 53 PCa 53 hemoglobin A1C 53 ‰ ¥ 53 subthreshold 53 dysthymia 53 DAS# remission 53 #q# deletion syndrome 53 donepezil 53 prespecified secondary 53 heterozygotes 53 comorbidity 53 creatinine ratio 53 Acute Physiology 53 SDQ 53 #.#ng/ml 53 prospectively defined 53 depressive symptoms 53 erythrocyte sedimentation rate 53 PANSS scores 53 psychosocial functioning 53 tertiles 53 HSCT 53 Ishak fibrosis score 53 attain statistical significance 53 PANSS Positive 53 primary aldosteronism 53 aMCI 53 Pearson correlation coefficients 53 Abnormal Involuntary Movement 53 aspartate aminotransferase 53 proband 53 IRLS 53 nondepressed 53 Depression Inventory BDI 53 ± SD 53 fasting glucose 53 schizophreniform disorder 53 semistructured interviews 53 fasting glucose levels 53 CC genotype 53 χ 53 intravaginal ejaculatory latency 53 serum HBV DNA 53 Cognitive Abilities Test 53 categorical variables 53 fractional anisotropy 53 nonresponders 53 ALSFRS R 53 μg liter 53 hippocampal volume 53 apolipoprotein B 53 secondary efficacy endpoint 53 Raven Progressive Matrices 52 periprocedural MI 52 multivariable Cox 52 MCID 52 left ventricular systolic 52 histologic 52 extensive metabolizers 52 premenopause 52 hsCRP levels 52 fasting plasma 52 SGAs 52 TEAEs 52 mmol l 52 randomized controlled trials RCTs 52 comorbid anxiety 52 prognostic variables 52 preoperatively 52 Severity Index 52 cognitive impairment 52 ischemic lesions 52 urodynamic parameters 52 nonobese 52 Scale PANSS 52 creatinine levels 52 methacholine challenge 52 achieved statistical significance 52 Negative Symptoms 52 Main Outcome Measure 52 Outcomes Study 52 eGFR 52 magnetic resonance spectroscopic imaging 52 logistic regression models 52 overnight polysomnography 52 UPDRS Part III 52 nondiabetic patients 52 LV ejection fraction 52 odds ratios ORs 52 CNS LS 52 APOC3 52 pain subscale 52 morphometric vertebral fractures 52 mmol L. 52 somatic symptoms 52 Specificity 52 BPH Symptom Score 52 urine albumin 52 intelligence quotient IQ 52 Timed Walk 52 Treatment Diabetic Retinopathy 52 thyrotropin levels 52 μg dL 52 DAS# CRP 52 AST ALT 52 plasma glucose concentration 52 generalized estimating 52 estimated glomerular filtration 52 psychiatric morbidity 52 mL/min/#.# m2 52 subsyndromal depression 52 Apgar scores 52 spirometric 52 SNP rs# [002] 52 estimated GFR 52 antibody titer 52 endoscopic remission 52 mIU L 52 ipsilateral stroke 52 serum creatinine 52 SGPT 52 nausea photophobia 52 Capacity FVC 52 pT3 52 Alanine 52 neuropsychological tests 52 platelet reactivity 52 Thrombolysis 52 fructosamine 52 PREZISTA r arm 52 Kaplan Meier estimates 52 Global Impression 52 UPDRS scores 52 affective psychoses 52 subsyndromal 52 interquartile range IQR 52 PASI scores 52 Histologic 52 Kellgren Lawrence 52 aminotransferase 52 HbA1C 52 metabolite concentrations 52 NSTEMI 52 Score TOS 52 extrapyramidal symptoms 52 interrater 52 Neuropsychological Status 52 Visual Analogue Scale 52 advanced adenoma 52 silent myocardial ischemia 52 postop 52 affective disorders 52 covariates 52 bivariate analyzes 52 Beck Anxiety Inventory 52 AUA BPH Symptom Score 52 % CI #.#-#.# [003] 52 CIN2 + 52 serum triglycerides 52 Non inferiority 52 amnestic mild cognitive impairment 52 posttransplant 52 ± SEM 52 Ejection Fraction 52 μmol L 52 Subscale 52 DLQI 52 APOE e4 52 Charlson Comorbidity Index 52 cardiac autonomic 52 psychomotor 52 postinjury 52 ug kg 52 microsatellite instability 52 UACR 52 completely resected 52 dyssynchrony 52 ROC curves 52 non affective psychosis 52 sensitivity specificity 52 MSLT 52 multivariate regression analysis 52 = #.#-#.# 52 rhinoconjunctivitis 52 International Prognostic Scoring 52 undetectable HBV DNA 51 meta analytic 51 LOCF 51 PLMS 51 logistic regression 51 serum prostate 51 Depression Rating Scale 51 verbal fluency 51 CTEPH 51 P ≤ 51 prespecified 51 serum PSA 51 diabetes mellitus DM 51 Comorbidity 51 crossclamp 51 FEV ^ sub 51 nasal symptom 51 Severity Index PASI 51 creatine kinase MB 51 HbA1C levels 51 Score DAS 51 advanced neoplasia 51 quantitative EEG 51 CR nPR 51 conditional logistic regression 51 aminotransferase levels 51 serum urate 51 hematologic toxicity 51 neurocognitive 51 glycosylated hemoglobin HbA1c 51 LV dysfunction 51 prospectively enrolled 51 HbA1c 51 QTcF 51 Structured Clinical 51 hippocampal volumes 51 FDG PET scans 51 ejection fractions 51 multiple logistic regression 51 activated partial thromboplastin 51 nerve conduction velocity 51 PERMP 51 PESQ 51 Platelet counts 51 nonparametric 51 untreated psychosis 51 IIQ 51 subclinical atherosclerosis 51 Female Sexual Function 51 mild cognitive impairment 51 serum creatinine levels 51 = .# 51 postprocedure 51 Hemoglobin A1c 51 % CI #.#-#.# [006] 51 Secondary endpoints 51 lymphopenia 51 Kruskal Wallis 51 cortical activation 51 6MWD 51 Poisson regression 51 psychiatric comorbidity 51 calculated creatinine clearance 51 eNO 51 Wechsler Memory 51 creatinine 51 exhaled nitric oxide 51 OSDI 51 rCBF 51 ULN 51 serum thyroglobulin 51 sustained ventricular tachycardia 51 PCWP 51 IQR 51 MDRD 51 D Dimer 51 tipranavir r 51 XIENCE V PROMUS Stent 51 Preoperatively 51 Univariate analysis 51 alexithymia 51 rs# [002] 51 multivariate logistic regression 51 haematologic 51 Visual acuity 51 eplerenone 51 GH deficiency 51 Operative mortality 51 postoperative complication 51 dyspnoea 51 ALS Functional 51 % CI #.#-#.# [007] 51 Physical Component 51 idiopathic Parkinson disease 51 diffusion tensor 51 Digit Symbol Substitution 51 baseline FEV 51 serum ALT 51 methotrexate monotherapy 51 % CI #.#-#.# [004] 51 cTnI 51 hematologic parameters 51 ALT elevations 51 pretreatment baseline 51 regression analyzes 51 serum cortisol 51 corticosteroid dose 51 aPTT 51 tPSA 51 adjunctive ABILIFY 51 kidney allograft 51 creatinine clearance 51 symptomatic intracranial hemorrhage 51 prostate cancer CaP 51 akinesia 51 rheumatoid factor 51 NPRS 51 pretest probability 51 interquartile range 51 BILAG 51 transcranial Doppler ultrasound 51 Neuropsychological 51 sociodemographic variables 51 CIN3 51 non menstrual pelvic 51 Distress Scale 51 hemoglobin concentration 51 pelvic lymphadenectomy 51 neuropsychiatric symptoms 51 elevated LDH 51 carotid intima media 51 comorbid diagnoses 51 Mania Rating Scale 51 apnea hypopnea 51 transient elastography 51 divalproex sodium 51 antitrypsin 51 HRCT 51 RNFL thickness 51 HBV DNA levels 51 mean baseline HbA1c 51 arterial thickening 51 decrements 51 exhaled NO 51 seropositivity 51 Secondary efficacy endpoints 51 euthymic 51 intact parathyroid hormone 51 CCyR 51 radiographic progression 51 NYHA 51 Erectile Function 51 LS BMD 51 hemoglobin A1c HbA1c 50 moderate renal impairment 50 Bonferroni 50 isoprostane 50 enthesitis 50 Flesch Kincaid 50 cystatin C 50 serum HCV RNA 50 lymphocyte count 50 arterial thromboembolic events 50 lactate dehydrogenase LDH 50 homozygotes 50 interobserver agreement 50 UPDRS II 50 plasma cortisol 50 neuropsychological 50 TRUS 50 psychiatric comorbidities 50 p = 50 systolic BP 50 binary logistic regression 50 annualized relapse 50 Common Toxicity Criteria 50 cortical atrophy 50 hepatocellular carcinomas 50 clinico pathological 50 PaO 2 50 emotional lability 50 plasma folate 50 genotypic resistance 50 nonpsychotic 50 esophageal carcinoma 50 glycated hemoglobin HbA1c 50 Stroke Scale NIHSS 50 Prostate specific antigen 50 p ≤ 50 hip BMD 50 abdominal pain abdominal discomfort 50 Solid Tumors RECIST 50 -#.# ± [002] 50 pCR 50 penetrance 50 Kaplan Meier curves 50 serum concentrations 50 HGPIN 50 MACCE 50 serum testosterone 50 adenotonsillectomy 50 SUVmax 50 metabolic parameters 50 somatoform disorders 50 conduction velocity 50 failure MTTF 50 hepatic enzyme 50 covariance 50 TT genotype 50 confirmed CCyR 50 clomipramine 50 probands 50 Kaplan Meier method 50 Glomerular filtration rate 50 suicide attempters 50 QTc interval 50 prognostic indicators 50 statistically nonsignificant 50 laboratory abnormalities 50 left ventricular LV 50 serum clusterin levels 50 sensory neuropathy 50 oral glucose tolerance 50 neutropaenia 50 Insulin sensitivity 50 Coronary artery calcium 50 multivariable adjusted 50 mammographic density 50 Functional Assessment 50 mU L 50 perioperative complications 50 Study ETDRS 50 Secondary endpoints included 50 X ULN 50 glycated hemoglobin levels 50 serologically active patients 50 oxygen desaturation 50 multivariate adjustment 50 Symptom Severity 50 hypoglycaemic episodes 50 Multivariate analysis 50 ≥ 50 Suicidal ideation 50 Depression Scale 50 Cardiotoxicity 50 serum urate levels 50 serum estradiol 50 erection hardness 50 subjective sleepiness 50 Injury Severity Score 50 parkinsonism 50 Erectile Function IIEF 50 urine NGAL 50 Lower Limb 50 serum folate 50 #OHD 50 NNT = 50 hours postdose 50 abnormal cytology 50 linear regression models 50 cells mcL 50 diameter stenosis 50 actigraphy 50 mg kg dose 50 plain radiographs 50 Likert type 50 PSA kinetics 50 evaluable subjects 50 SSRI citalopram 50 comorbid depression 50 p = .# [001] 50 p = #.# [002] 50 leukocyte count 50 dichotomized 50 Mild Cognitive Impairment 50 Outcome Measures 50 homocysteine concentrations 50 #F FDG PET 50 pg ml 50 Mild cognitive impairment 50 Scale Revised 50 symptomatology 50 dose atorvastatin 50 Prognostic Index 50 AUA Symptom Score 50 CIBIC + 50 Child Behavior Checklist 50 electrophysiologic 50 psychopathological symptoms 50 CI #.#-#.# [001] 50 lispro 50 ECOG PS 50 SGOT 50 progression TTP 50 -#.# log# 50 peak VO2 50 clinicopathological features 50 dyspnea 50 dose Iluvien 50 mild cognitive 50 hypertensives 50 A1c levels 50 VaD 50 Stent thrombosis 50 semistructured interview 49 hs CRP 49 preintervention 49 CSF biomarkers 49 placebo p = 49 aortic regurgitation 49 Symptom severity 49 System IPSS 49 bronchopulmonary dysplasia 49 Approaching Basic 49 QTc intervals 49 Depressive Symptoms 49 concomitant medications 49 confidence interval #.#-#.# 49 HBeAg seroconversion 49 lymphocytosis 49 Forced Vital 49 adjunctive placebo 49 histological subtype 49 hemoglobin Hb 49 CP CPPS 49 serum sodium 49 albuminuria 49 CrCl 49 meta regression 49 death reinfarction 49 cognitive functioning 49 SSRI SNRI 49 polysomnography 49 nmol L 49 androgen suppression 49 ALT flares 49 TIMP 1 49 mean baseline A1C 49 df = 49 MDQ 49 elevated creatinine 49 APOE genotype 49 alteplase 49 noncarriers 49 postoperatively 49 receiving VICTRELIS 49 hyperintensity 49 ACR# ACR# 49 clinically meaningful reductions 49 arterial oxygen saturation 49 cognitively normal 49 colesevelam 49 serum glucose 49 mmHg diastolic 49 blood Phe levels 49 serum parathyroid hormone 49 GERD symptom 49 hypoglycemic episodes 49 PsA 49 carotid stenosis 49 cTnT levels 49 Verbal Learning 49 hematological parameters 49 OSAHS 49 statistically significant p = 49 Confidence Intervals 49 Prognostic 49 x ULN 49 serum bilirubin 49 subclinical hypothyroidism 49 Severity MSCS score 49 VT VF 49 sociodemographic characteristics 49 ß = 49 Neuroticism 49 euthyroid 49 IL#B 49 cerebral perfusion 49 prevalences 49 infarct size 49 LUTS 49 predictive validity 49 radical prostatectomy RP 49 vascular cognitive impairment 49 underwent coronary angiography 49 chronicity 49 Perceived Stress Scale 49 coronary artery calcium 49 maximal treadmill 49 dexamethasone suppression 49 memantine Namenda 49 ertapenem 49 COMT genotype 49 Urogenital Distress Inventory 49 atheroma volume 49 hypocalcemia 49 serum ferritin 49 psychiatric outpatients 49 criterion referenced 49 myocardial viability 49 neurobehavioral functioning 49 FDG-PET/CT 49 transaminase levels 49 ACR# [002] 49 noncognitive 49 serum TSH 49 mEq L 49 antigen PSA levels 49 plasma leptin 49 STRIDE PD 49 Assessment Scale 49 nmol liter 49 Wechsler Intelligence 49 achieved ACR# 49 bronchial hyperresponsiveness 49 TURBT 49 hepatic enzymes 49 procalcitonin 49 microvessel density 49 cerebral glucose metabolism 49 microg 49 overt hypothyroidism 49 immunostaining 49 GAMMAGARD 49 severe exacerbations 49 statistically significant 49 adiponectin concentrations 49 symptom checklist 49 immunohistochemical analysis 49 severe neutropenia 49 leukocyte counts 49 p = NS 49 underwent resection 49 Cronbach 49 impaired fasting glucose 49 EPDS 49 neurosensory 49 clinicopathological 49 poor metabolizers 49 immunohistochemical 49 -#.# mg dL [002] 49 r2 = 49 troponin T 49 QOL 49 neuropsychological deficits 49 hydroxyvitamin D levels 49 FDG PET 49 etiologic 49 SerDes transceivers 49 divalproex 49 liver biopsies 49 6MWT 49 Endothelial function 49 Functioning GAF 49 serum potassium 49 ALT AST 49 CPAP adherence 49 SNHL 49 mild cognitive impairments 49 echocardiographic parameters 49 Cholinesterase Inhibitors 49 statistical significance p 49 colorectal adenomas 49 systolic 49 non squamous NSCLC 49 Bayley Scales 49 d dimer 49 Intelligence Quotient IQ 49 Non Responders 49 salivary cortisol 49 statistical significance 49 κ 49 prognostic significance 49 tryptophan depletion 49 cerebrovascular events 49 confidence interval CI 49 RAPAFLO R 49 ECLS 49 Chronic Illness Therapy 49 desvenlafaxine succinate 49 CI = 49 sUA 49 noninferiority 49 mm Hg systolic 49 T1a 49 bivalirudin monotherapy 49 plasma glucose 49 CK MB 49 atrioventricular block 49 % CI #.#-#.# [001] 49 Comorbidities 49 ng dL 49 flutamide 49 rs# [001] 49 mm Hg diastolic 49 ROC curve 49 CR CRu 49 Predictors 49 parkinsonian 49 mRNA expression 49 venlafaxine XR 49 MADRS scores 49 log# copies mL 49 Severity Scale 49 gadolinium enhancing 48 Decitabine 48 fasting plasma glucose FPG 48 somatization disorder 48 graft dysfunction 48 neutrophil counts 48 blood Phe 48 nadroparin 48 carotid artery thickness 48 aortic crossclamp 48 unfavorable cytogenetics 48 VKORC1 48 episodic migraine 48 cytologic 48 Secondary endpoints include 48 r = 48 Charlson comorbidity index 48 proteinuria 48 familial AF 48 cerebral infarction 48 serum calcium levels 48 Hb A1c 48 variant allele 48 Polymorphism 48 abdominal adiposity 48 recurrent VTE 48 paresthesias 48 seminal vesicle invasion 48 rFSH 48 nmol L.